In an 87-year-old female with an incidentally discovered moderate atheromatous plaque in the left carotid bulb, what are the appropriate management recommendations?

Management of Incidental Moderate Carotid Plaque in an 87-Year-Old Female

Initiate intensive medical therapy immediately without surgical intervention—this patient should receive aspirin 75-325 mg daily, high-intensity statin therapy, blood pressure control to <140/90 mmHg (or <130/80 if tolerated), and risk factor modification, with surgical revascularization reserved only if she develops neurological symptoms. 1

Primary Recommendation: Medical Management

At 87 years old with an incidental (asymptomatic) finding of moderate stenosis, this patient falls squarely into the category where modern medical therapy has dramatically reduced stroke risk to <1% annually 2. The 2011 AHA/ASA guidelines establish the foundation for management, though recent evidence through 2026 reinforces that best medical therapy has evolved substantially and now rivals or exceeds revascularization benefits in asymptomatic patients 3.

Core Medical Therapy Components

Antiplatelet therapy is the cornerstone:

• Start aspirin 75-325 mg daily immediately 1
• Alternative options include clopidogrel 75 mg daily or aspirin plus extended-release dipyridamole (25/200 mg twice daily) 1
• Continue indefinitely for long-term prophylaxis against ischemic cardiovascular events 1

Statin therapy should be initiated regardless of baseline lipid levels:

• High-intensity statin therapy is reasonable for all patients with carotid atherosclerosis 1
• Recent advances include PCSK9 inhibitors for intensive lipid-lowering when statins alone are insufficient 3
• Statins provide plaque stabilization beyond cholesterol reduction through endothelial stabilization and anti-inflammatory effects 4

Blood pressure management is critical:

• Target <140/90 mmHg at minimum; <130/80 mmHg if tolerated without compromising cerebral perfusion 5
• Antihypertensive medication should be administered as needed 1

Why Not Surgery in This Case?

The age factor is decisive here. In octogenarians, CEA carries a 1% stroke risk and CAS carries a 3% stroke risk 1, which must be weighed against the natural history of asymptomatic moderate stenosis. The procedural risks approach or exceed the annual stroke risk from the plaque itself.

Current guidelines reserve revascularization for:

• Symptomatic stenosis >50-70% (this patient is asymptomatic) 1, 2
• Asymptomatic stenosis >60% with high-risk features AND acceptable surgical risk 2

At 87 years with only "moderate" plaque (typically <60% stenosis), neither threshold is met.

Surveillance Strategy

Noninvasive imaging surveillance is reasonable but should be time-limited 1:

• Duplex ultrasound at 1 month, 6 months, then annually initially 1
• Once stability is established, extend intervals or terminate surveillance when the patient is no longer a candidate for intervention 1
• Given her age, aggressive surveillance may be discontinued after establishing baseline stability

Critical Pitfalls to Avoid

1. Do not pursue revascularization based on stenosis percentage alone in asymptomatic elderly patients—the procedural risks outweigh benefits 3, 2

2. Do not withhold statin therapy even if lipids are "normal"—the plaque-stabilizing effects are independent of cholesterol lowering 1, 4

3. Do not assume "asymptomatic" means benign—specifically assess for subtle cognitive changes or unrecognized TIAs, as these would reclassify the patient as symptomatic 3

4. In this age group, mortality from competing causes (cardiac disease, other vascular events) often exceeds stroke risk from the carotid plaque itself 6

When to Reconsider Intervention

Revascularization becomes appropriate if:

• Patient develops any neurological symptoms ipsilateral to the plaque (TIA, amaurosis fugax, stroke)
• Stenosis progresses to severe (>70%) AND patient develops high-risk plaque features on imaging (intraplaque hemorrhage, ulceration, echolucent/lipid-rich plaque) 7, 8
• Patient remains in excellent functional status with life expectancy >5 years and stenosis progresses significantly

The evidence strongly favors medical management in this specific clinical scenario—an elderly asymptomatic patient with moderate disease where contemporary medical therapy has fundamentally changed the risk-benefit calculus compared to older surgical trials 3, 2.